{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:18:43Z","timestamp":1783991923516,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Helsinki University Hospital","award":["EVO grant"],"award-info":[{"award-number":["EVO grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10096-019-03560-9","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T11:03:07Z","timestamp":1555930987000},"page":"1351-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Factors associated with blood culture positivity in patients with complicated skin and skin structure infection\u2014a population-based study"],"prefix":"10.1007","volume":"38","author":[{"given":"Mika","family":"Halavaara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iiro H.","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asko","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"3560_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jama.2016.8825","volume":"316","author":"AB Raff","year":"2016","unstructured":"Raff AB, Kroshinsky D (2016) Cellulitis: a review. JAMA 316:325\u2013337","journal-title":"JAMA"},{"key":"3560_CR2","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3201\/eid1509.081228","volume":"15","author":"J Edelsberg","year":"2009","unstructured":"Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G (2009) Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 15:1516\u20131518","journal-title":"Emerg Infect Dis"},{"key":"3560_CR3","doi-asserted-by":"publisher","first-page":"e0143276","DOI":"10.1371\/journal.pone.0143276","volume":"10","author":"KS Kaye","year":"2015","unstructured":"Kaye KS, Patel DA, Stephens JM, Khachatryan A, Patel A, Johnson K (2015) Rising United States hospital admissions for acute bacterial skin and skin structure infections: recent trends and economic impact. PLoS One 10:e0143276","journal-title":"PLoS One"},{"key":"3560_CR4","unstructured":"Center for Drug Evaluation and Research, Food and Drug Administration (1998) Guidance for industry: uncomplicated and complicated skin and skin structure infections - developing antimicrobial drugs for treatment. Washington, DC: Food and Drug Administration, US Department of Health and Human Services"},{"issue":"Suppl 3","key":"3560_CR5","first-page":"iii35","volume":"65","author":"MS Dryden","year":"2010","unstructured":"Dryden MS (2010) Complicated skin and soft tissue infection. J Antimicrob Chemother 65(Suppl 3):iii35\u2013iii44","journal-title":"J Antimicrob Chemother"},{"key":"3560_CR6","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59:e10\u2013e52","journal-title":"Clin Infect Dis"},{"key":"3560_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jama.2012.8262","volume":"308","author":"B Coburn","year":"2012","unstructured":"Coburn B, Morris AM, Tomlinson G, Detsky AS (2012) Does this adult patient with suspected bacteremia require blood cultures? JAMA 308:502\u2013511","journal-title":"JAMA"},{"key":"3560_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1086\/313525","volume":"29","author":"B Perl","year":"1999","unstructured":"Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM (1999) Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 29:1483\u20131488","journal-title":"Clin Infect Dis"},{"key":"3560_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jemermed.2013.01.016","volume":"45","author":"WF Paolo","year":"2013","unstructured":"Paolo WF, Poreda AR, Grant W, Scordino D, Wojcik S (2013) Blood culture results do not affect treatment in complicated cellulitis. J Emerg Med 45:163\u2013167","journal-title":"J Emerg Med"},{"key":"3560_CR10","first-page":"148","volume":"64","author":"CG Gunderson","year":"2012","unstructured":"Gunderson CG, Martinello RA (2012) A systematic review of bacteremias in cellulitis and erysipelas. J Inf Secur 64:148\u2013155","journal-title":"J Inf Secur"},{"key":"3560_CR11","doi-asserted-by":"publisher","first-page":"E377","DOI":"10.1111\/1469-0691.12235","volume":"19","author":"J Garau","year":"2013","unstructured":"Garau J, Ostermann H, Medina J, Avila M, McBride K, Blasi F, REACH study group (2013) Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. Clin Microbiol Infect 19:E377\u2013E385","journal-title":"Clin Microbiol Infect"},{"key":"3560_CR12","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s10096-017-3001-0","volume":"36","author":"FV Daalen van","year":"2017","unstructured":"van Daalen FV, Kallen MC, van den Bosch CMA, Hulscher MEJL, Geerlings SE, Prins JM (2017) Clinical condition and comorbidity as determinants for blood culture positivity in patients with skin and soft-tissue infections. Eur J Clin Microbiol Infect Dis 36:1853\u20131858","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3560_CR13","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1086\/654007","volume":"31","author":"BA Lipsky","year":"2010","unstructured":"Lipsky BA, Kollef MH, Miller LG, Sun X, Johannes RS, Tabak YP (2010) Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol 31:828\u2013837","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3560_CR14","doi-asserted-by":"publisher","first-page":"383.e1","DOI":"10.1016\/j.cmi.2016.01.002","volume":"22","author":"IH Jaaskelainen","year":"2016","unstructured":"Jaaskelainen IH, Hagberg L, From J, Schyman T, Lehtola L, Jarvinen A (2016) Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden. Clin Microbiol Infect 22:383.e1\u2013383.e10","journal-title":"Clin Microbiol Infect"},{"key":"3560_CR15","doi-asserted-by":"publisher","first-page":"674.e1","DOI":"10.1016\/j.cmi.2017.02.033","volume":"23","author":"IH Jaaskelainen","year":"2017","unstructured":"Jaaskelainen IH, Hagberg L, Forsblom E, Jarvinen A (2017) Factors associated with time to clinical stability in complicated skin and skin structure infections. Clin Microbiol Infect 23:674.e1\u2013674.e5","journal-title":"Clin Microbiol Infect"},{"key":"3560_CR16","unstructured":"Jaakola S, Lyytik\u00e4inen O, Rimhanen-Finne R, Salmenlinna S, Vuopio J, Roivainen M, L\u00f6flund J, Kuusi M, Ruutu P (2012) Tartuntataudit Suomessa 2011 [Infectious Diseases in Finland 2011]. Terveyden ja Hyvinvoinnin Laitos [National Institute for Health and Welfare]. Available at: \n                    http:\/\/urn.fi\/URN:ISBN:978-952-245-658-8"},{"key":"3560_CR17","unstructured":"European Centre for Disease Prevention and Control (2012) Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm"},{"key":"3560_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/23744235.2017.1362706","volume":"50","author":"IH Jaaskelainen","year":"2018","unstructured":"Jaaskelainen IH, Hagberg L, Schyman T, Jarvinen A (2018) A potential benefit from infectious disease specialist and stationary ward in rational antibiotic therapy of complicated skin and skin structure infections. Infect Dis (Lond) 50:107\u2013116","journal-title":"Infect Dis (Lond)"},{"key":"3560_CR19","doi-asserted-by":"publisher","first-page":"402\u2013015\u20131134-2","DOI":"10.1186\/s12879-015-1134-2","volume":"15","author":"A Blackberg","year":"2015","unstructured":"Blackberg A, Trell K, Rasmussen M (2015) Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infect Dis 15:402\u2013015\u20131134-2","journal-title":"BMC Infect Dis"},{"key":"3560_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejim.2016.07.029","volume":"36","author":"S Bauer","year":"2016","unstructured":"Bauer S, Aubert CE, Richli M, Chuard C (2016) Blood cultures in the evaluation of uncomplicated cellulitis. Eur J Intern Med 36:50\u201356","journal-title":"Eur J Intern Med"},{"key":"3560_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10096-006-0186-z","volume":"25","author":"G Peralta","year":"2006","unstructured":"Peralta G, Padron E, Roiz MP, De Benito I, Garrido JC, Talledo F, Rodriguez-Lera MJ, Ansorena L, Sanchez MB (2006) Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis 25:619\u2013626","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3560_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10096-006-0187-y","volume":"25","author":"LJ Eron","year":"2006","unstructured":"Eron LJ, Lipsky BA (2006) Use of cultures in cellulitis: when, how, and why? Eur J Clin Microbiol Infect Dis 25:615\u2013661","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03560-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03560-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03560-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T14:27:30Z","timestamp":1567088850000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03560-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03560-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MH has received a lecture fee from OrionPharma, Ratiopharm and MSD; a conference invitation from Gilead; and has recent consultancies with Pfizer. IHJ has received a conference invitation from Gilead. AJ has received speaker\u2019s honoraria from Astellas, Cardiome, MSD, OrionPharma, Pfizer, Ratiopharm and Unimedic; and congress support from MSD and Steripolar.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by both study sites in local conventional manner and by the ethical committee of Sahlgrenska University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}